LAG-3 Confers a Competitive Disadvantage upon Antiviral CD8+ T Cell Responses.

about

Not All Immune Checkpoints Are Created Equal

P2860

Q56889626-AE1B2637-A759-43FB-AB11-CE0E41BD86AC

P2860

LAG-3 Confers a Competitive Disadvantage upon Antiviral CD8+ T Cell Responses.

Item

http://www.wikidata.org/entity/Q39748865

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

LAG-3 Confers a Competitive Disadvantage upon Antiviral CD8+ T Cell Responses.

@en

LAG-3 Confers a Competitive Disadvantage upon Antiviral CD8+ T Cell Responses.

@nl

type

Item

label

LAG-3 Confers a Competitive Disadvantage upon Antiviral CD8+ T Cell Responses.

@en

LAG-3 Confers a Competitive Disadvantage upon Antiviral CD8+ T Cell Responses.

@nl

prefLabel

LAG-3 Confers a Competitive Disadvantage upon Antiviral CD8+ T Cell Responses.

@en

LAG-3 Confers a Competitive Disadvantage upon Antiviral CD8+ T Cell Responses.

@nl

P1476

LAG-3 Confers a Competitive Disadvantage upon Antiviral CD8+ T Cell Responses.

@en

P2093

Jason K Whitmire

http://www.w3.org/2001/XMLSchema#string

Kevin D Cook

http://www.w3.org/2001/XMLSchema#string

P2860

LAG-3, a novel lymphocyte activation gene closely related to CD4

Characterization of the major histocompatibility complex class II binding site on LAG-3 protein

Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens

Immunotherapy in the treatment of non-small cell lung cancer

Bim/Bcl-2 balance is critical for maintaining naive and memory T cell homeostasis

Independent modes of natural killing distinguished in mice lacking Lag3

T cell exhaustion

Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer.

Lymphocyte activation gene-3, a MHC class II ligand expressed on activated T cells, stimulates TNF-alpha and IL-12 production by monocytes and dendritic cells.

The MHC class II ligand lymphocyte activation gene-3 is co-distributed with CD8 and CD3-TCR molecules after their engagement by mAb or peptide-MHC class I complexes.

P304

119-127

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1401594

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

197

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27206765

http://www.w3.org/2001/XMLSchema#string

P932

5662018

http://www.w3.org/2001/XMLSchema#string

LAG-3 Confers a Competitive Disadvantage upon Antiviral CD8+ T Cell Responses.

about

P2860

P2860

LAG-3 Confers a Competitive Disadvantage upon Antiviral CD8+ T Cell Responses.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932